Skip to content
Company Analysis

Bone Biologics Corp BBLG

A comprehensive view of key metrics, scores, and financial health for Bone Biologics Corp

Overview of Bone Biologics Corporation

BBLG NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Bone Biologics Corporation (BBLG), is a Micro Cap company, in the Medical Devices industry, last closed at $1.25, about 0.0% overvalued vs fair value, -73.8% 1Y return, placing in the top 10% of its sector.
USD 1.25
-1.57%
(Delayed)
• Vol 90d: 48.9%
52-Week Range
Market Cap
$2.23M
Enterprise Value
$-3.82M
Overall Score
View breakdown
Overall
Growth
Excellent
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Fair
Growth
Excellent
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Fair
Completeness: 76%
Confidence: 66%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.bonebiologics.com
HQ Burlington, MA
Employees 2
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
Free Cash Flow
$-4.1M
56.8%%
Capital Allocation
$-3.2M
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

FCF Conversion
100%
Excellent

Free Cash Flow / Net Income — MedTech quality hallmark. ≥100% is typical and desirable; M&A amortisation makes GAAP NI lower than true cash earnings.

Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$3.2M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Bone Biologics Corp's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
22
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger

Where management spends the performance budget

Insufficient Data for Analysis

BBLG - Bone Biologics Corp

We have limited financial data for BBLG. The Growth and Profitability axes don't have enough metrics for reliable analysis.

Data Coverage by Axis

Growth
25% coverage Below threshold
Profitability
30% coverage
Overall Coverage: 35.0% (Minimum 40% required)

What This Means

  • Currently at 35.0% data coverage (minimum 40% required)
  • Check back after quarterly or annual filings
  • Some metrics may not be applicable to this company's business model

What can you do?

  • View available sections like Moat Map or Engine Room for partial insights
  • Set up a watchlist alert to be notified when new data becomes available
  • Compare with peers in the same industry that have complete data

Two Futures

Scenario-based fair value ranges for Bone Biologics Corp.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000